Free Trial
→ SpaceX will mint billionaires. You won't be one of them. (From Behind the Markets) (Ad)tc pixel Free AMSF Stock Alerts

AMERISAFE (AMSF) Financials

AMERISAFE logo
$31.53 0.00 (0.00%)
Closing price 06/12/2026 04:00 PM Eastern
Extended Trading
$31.56 +0.04 (+0.11%)
As of 06/12/2026 05:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare
Annual Income Statements for AMERISAFE

Annual Income Statements for AMERISAFE

This table shows AMERISAFE's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2014 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Net Income / (Loss) Attributable to Common Shareholders		 54 70 78 46 72 93 87 66 56 62 55
Consolidated Net Income / (Loss)		 54 70 78 46 72 93 87 66 56 62 55
Net Income / (Loss) Continuing Operations		 54 70 78 46 72 93 87 66 56 62 55
Total Pre-Tax Income 		74 101 113 82 88 116 107 79 68 77 69
Total Revenue		 404 401 397 375 378 370 339 316 295 307 309
Net Interest Income / (Expense)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Interest Income		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Non-Interest Income		 404 401 397 375 378 370 339 316 295 307 309
Other Service Charges		 0.36 0.32 0.35 0.42 0.60 0.32 0.35 0.50 0.47 0.58 0.26
Net Realized & Unrealized Capital Gains on Investments		 28 25 28 29 27 37 35 39 23 39 38
Premiums Earned		 376 376 369 346 350 333 304 276 272 267 271
Total Non-Interest Expense		 330 300 284 293 290 255 233 236 227 229 240
Salaries and Employee Benefits		 52 52 51 50 52 52 51 47 48 51 55
Property & Liability Insurance Claims		 245 216 203 214 209 181 157 165 155 148 157
Insurance Policy Acquisition Costs		 33 32 29 28 29 22 24 25 24 30 28
Other Operating Expenses		 - - - - - - -0.03 -0.08 0.04 -0.06 -0.07
Income Tax Expense		 20 31 35 36 16 23 20 14 12 15 14
Basic Earnings per Share		 $2.88 $3.72 $4.08 $2.41 $3.73 $4.82 $4.49 $3.40 $2.89 $3.24 $2.91
Weighted Average Basic Shares Outstanding		 18.65M 18.94M 19.11M 19.17M 19.21M 19.25M 19.29M 19.33M 19.23M 19.15M 19.07M
Diluted Earnings per Share		 $2.84 $3.69 $4.05 $2.40 $3.71 $4.80 $4.47 $3.39 $2.88 $3.23 $2.89
Weighted Average Diluted Shares Outstanding		 18.93M 19.12M 19.20M 19.25M 19.29M 19.33M 19.36M 19.41M 19.32M 19.23M 19.16M
Weighted Average Basic & Diluted Shares Outstanding		 18.60M 18.90M 19.10M 19.20M 19.20M 19.20M 19.33M 19.36M 19.16M 19.14M 19.05M
Cash Dividends to Common per Share		 $0.48 $0.60 $0.72 $0.80 $0.88 $1.00 $1.08 $1.16 $1.24 $1.36 $1.48

Quarterly Income Statements for AMERISAFE

This table shows AMERISAFE's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025
Period end date 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025
Net Income / (Loss) Attributable to Common Shareholders		 17 16 9.96 19 17 11 14 13 8.95 14 14
Consolidated Net Income / (Loss)		 17 16 9.96 19 17 11 14 13 8.95 14 14
Net Income / (Loss) Continuing Operations		 17 16 9.96 19 17 11 14 13 8.95 14 14
Total Pre-Tax Income 		22 20 12 24 21 14 18 17 11 17 17
Total Revenue		 78 76 73 80 80 76 79 74 73 81 82
Net Interest Income / (Expense)		 0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00 0.00 0.00
Total Interest Income		 0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00 0.00 0.00
Total Interest Expense		 0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00 0.00 0.00
Total Non-Interest Income		 78 76 73 80 80 76 79 74 73 81 82
Other Service Charges		 0.20 0.21 0.08 0.09 0.12 -0.08 0.13 0.08 0.21 0.07 0.10
Net Realized & Unrealized Capital Gains on Investments		 9.06 9.85 5.93 14 12 7.27 12 7.44 3.50 12 11
Premiums Earned		 69 66 67 66 68 69 67 67 69 69 71
Total Non-Interest Expense		 57 56 60 56 60 62 61 57 61 64 64
Salaries and Employee Benefits		 12 13 13 14 13 13 13 15 14 14 15
Property & Liability Insurance Claims		 40 36 38 34 41 42 40 35 41 42 42
Insurance Policy Acquisition Costs		 5.16 7.43 9.49 8.39 5.31 7.27 7.87 7.08 6.26 8.05 7.59
Other Operating Expenses		 -0.02 -0.02 -0.02 -0.01 -0.02 -0.02 -0.01 -0.02 -0.02 -0.01 -0.01
Income Tax Expense		 4.20 3.94 2.37 4.77 3.82 2.75 3.47 3.58 2.27 3.50 3.66
Basic Earnings per Share		 $0.91 $0.82 $0.52 $0.99 $0.89 $0.58 $0.75 $0.69 $0.47 $0.73 $0.73
Weighted Average Basic Shares Outstanding		 19.13M 19.14M 19.16M 19.15M 19.12M 19.08M 19.04M 19.07M 19.04M 19.04M 18.98M
Diluted Earnings per Share		 $0.90 $0.81 $0.52 $1.00 $0.88 $0.57 $0.75 $0.69 $0.47 $0.73 $0.72
Weighted Average Diluted Shares Outstanding		 19.24M 19.20M 19.22M 19.23M 19.21M 19.15M 19.11M 19.16M 19.15M 19.12M 19.07M
Weighted Average Basic & Diluted Shares Outstanding		 19.15M 19.18M 19.18M 19.14M 19.14M 19.07M 19.05M 19.05M 19.05M 18.99M 18.92M
Cash Dividends to Common per Share		 $0.34 $0.34 $0.34 $0.34 $0.37 $0.37 $0.37 $0.37 $0.39 $0.39 $0.39

Annual Cash Flow Statements for AMERISAFE

This table details how cash moves in and out of AMERISAFE's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2014 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Net Change in Cash & Equivalents		 -32 -21 -11 -3.38 -15 3.47 18 8.97 -9.25 -23 5.36
Net Cash From Operating Activities		 141 93 114 131 98 79 63 38 28 30 24
Net Cash From Continuing Operating Activities		 141 93 114 131 98 79 63 38 28 30 24
Net Income / (Loss) Continuing Operations		 54 70 78 46 72 93 87 66 56 62 55
Consolidated Net Income / (Loss)		 54 70 78 46 72 93 87 66 56 62 55
Depreciation Expense		 1.30 1.35 1.18 0.98 1.00 0.94 1.01 1.02 1.31 1.43 1.09
Amortization Expense		 15 16 16 14 11 8.66 8.18 8.87 6.73 3.03 1.45
Non-Cash Adjustments to Reconcile Net Income		 -0.59 5.83 -0.14 15 -2.29 -1.45 -0.35 -10 6.00 -5.62 -4.38
Changes in Operating Assets and Liabilities, net		 71 -1.20 19 54 17 -22 -32 -27 -41 -31 -29
Net Cash From Investing Activities		 -141 -50 -50 -52 -29 12 43 71 75 44 72
Net Cash From Continuing Investing Activities		 -141 -50 -50 -52 -29 12 43 71 75 44 72
Purchase of Property, Leasehold Improvements and Equipment		 -0.99 -0.95 -1.64 -0.48 -1.13 -1.02 -0.92 -1.30 -2.09 -0.55 -0.84
Purchase of Investment Securities		 -453 -326 -355 -402 -368 -346 -321 -271 -215 -134 -111
Sale and/or Maturity of Investments		 313 277 306 351 340 359 365 343 293 178 184
Net Cash From Financing Activities		 -32 -65 -74 -83 -84 -87 -89 -100 -113 -97 -91
Net Cash From Continuing Financing Activities		 -32 -65 -74 -83 -84 -87 -89 -100 -113 -97 -91
Repayment of Debt		 - - - 0.00 - - - -0.04 -0.06 -0.09 -0.09
Repurchase of Common Equity		 - - - - - - 0.00 0.00 -12 -2.17 -5.12
Payment of Dividends		 -37 -69 -76 -83 -84 -87 -89 -100 -100 -93 -85
Other Financing Activities, Net		 5.52 4.05 1.83 0.00 0.07 -0.03 -0.05 0.00 0.00 -0.94 -0.55
Cash Income Taxes Paid		 20 24 32 28 11 21 21 18 7.79 14 12

Quarterly Cash Flow Statements for AMERISAFE

This table details how cash moves in and out of AMERISAFE's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025
Period end date 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025
Net Change in Cash & Equivalents		 -20 -7.29 25 -21 -5.31 -2.76 33 -20 0.71 3.71 6.28
Net Cash From Operating Activities		 13 7.28 5.13 3.97 7.51 -2.59 8.45 11 -1.79 -8.44 11
Net Cash From Continuing Operating Activities		 13 7.31 5.15 3.97 7.51 -2.56 8.46 11 -1.79 -8.42 11
Net Income / (Loss) Continuing Operations		 17 16 9.96 19 17 11 14 13 8.95 14 14
Consolidated Net Income / (Loss)		 17 16 9.96 19 17 11 14 13 8.95 14 14
Depreciation Expense		 0.35 0.35 0.37 0.36 0.33 0.23 0.28 0.26 0.21 0.20 0.18
Amortization Expense		 1.09 0.78 0.51 0.65 0.52 0.33 0.23 0.37 0.26 0.19 0.05
Non-Cash Adjustments to Reconcile Net Income		 -1.45 -2.76 2.60 -4.01 -4.25 0.73 -2.82 1.96 4.12 -5.07 -3.16
Changes in Operating Assets and Liabilities, net		 -3.87 -6.69 -8.29 -12 -6.01 -15 -3.55 -4.93 -15 -18 -0.23
Net Cash From Investing Activities		 -27 -7.15 27 51 -5.72 11 33 34 9.95 23 4.61
Net Cash From Continuing Investing Activities		 -27 -7.15 27 51 -5.72 11 33 34 9.95 23 4.61
Purchase of Property, Leasehold Improvements and Equipment		 -0.03 -0.01 -0.49 -0.03 -0.75 -0.06 -0.02 -0.01 -0.00 -1.08 -0.89
Purchase of Investment Securities		 -51 -43 -29 -10 -42 -17 -27 -24 -10 -9.68 -20
Sale and/or Maturity of Investments		 24 36 57 62 37 29 60 58 20 34 25
Net Cash From Financing Activities		 -6.53 -7.42 -6.76 -76 -7.10 -12 -8.23 -64 -7.45 -11 -9.01
Net Cash From Continuing Financing Activities		 -6.53 -7.42 -6.76 -76 -7.10 -12 -8.23 -64 -7.45 -11 -9.01
Repurchase of Common Equity		 - - - -2.17 - - -1.01 -0.00 - - -1.35
Payment of Dividends		 -6.51 -6.62 -6.57 -74 -7.08 -7.10 -7.09 -64 -7.42 -7.49 -7.50
Other Financing Activities, Net		 -0.02 -0.76 -0.17 - -0.02 -0.41 -0.11 -0.01 -0.02 -0.65 -0.20

Annual Balance Sheets for AMERISAFE

This table presents AMERISAFE's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2014 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Total Assets		 1,457 1,502 1,519 1,518 1,516 1,493 1,471 1,403 1,269 1,229 1,158
Cash and Due from Banks		 91 69 59 56 40 44 62 71 61 39 44
Trading Account Securities		 971 1,025 1,042 1,105 1,125 526 504 463 889 374 789
Loans and Leases, Net of Allowance		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Accrued Investment Income		 12 12 11 11 10 9.73 9.27 8.08 8.43 8.27 7.33
Premises and Equipment, Net		 7.24 6.18 6.64 6.13 6.26 6.33 6.18 6.46 7.23 6.35 5.89
Unearned Premiums Asset		 179 185 183 174 162 158 157 135 122 133 143
Deferred Acquisition Cost		 20 20 19 20 20 19 18 17 17 18 19
Other Assets		 178 184 198 147 151 730 715 702 164 651 150
Total Liabilities & Shareholders' Equity		 1,457 1,502 1,519 1,518 1,516 1,493 1,471 1,403 1,269 1,229 1,158
Total Liabilities		 1,010 1,048 1,063 1,093 1,106 1,063 1,032 1,003 952 937 900
Claims and Claim Expense		 688 718 743 772 798 773 761 745 696 674 651
Unearned Premiums Liability		 169 168 162 157 149 141 129 121 115 117 122
Participating Policy Holder Equity		 49 48 49 48 47 45 42 39 36 35 34
Other Long-Term Liabilities		 105 114 109 115 112 104 101 98 105 112 93
Total Equity & Noncontrolling Interests		 447 454 456 425 410 430 439 399 317 292 257
Total Preferred & Common Equity		 447 454 456 425 410 430 439 399 317 292 257
Total Common Equity		 447 454 456 425 410 430 439 399 317 292 257
Common Stock		 199 205 209 210 212 213 216 218 221 222 224
Retained Earnings		 267 269 270 234 221 227 225 190 146 114 84
Treasury Stock		 -22 -22 -22 -22 -22 -22 -22 -22 -35 -37 -42
Accumulated Other Comprehensive Income / (Loss)		 2.81 2.59 -0.49 3.61 -0.83 12 21 14 -14 -7.19 -8.88

Quarterly Balance Sheets for AMERISAFE

This table presents AMERISAFE's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q2 2022 Q3 2022 Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025
Period end date 6/30/2022 9/30/2022 3/31/2023 6/30/2023 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025
Total Assets		 1,382 1,359 1,288 1,299 1,297 1,243 1,234 1,255 1,157 1,155 1,165
Cash and Due from Banks		 85 91 41 34 59 33 31 64 45 48 55
Trading Account Securities		 425 420 920 929 889 101 389 399 67 374 762
Loans and Leases, Net of Allowance		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Accrued Investment Income		 8.23 8.77 8.64 8.39 8.55 8.25 8.18 8.19 7.75 7.46 7.63
Premises and Equipment, Net		 6.89 7.38 6.91 6.56 6.68 6.77 6.38 6.13 5.68 6.56 7.27
Unearned Premiums Asset		 143 137 137 142 144 144 151 153 157 166 168
Deferred Acquisition Cost		 18 18 19 19 19 19 20 20 20 21 22
Other Assets		 695 677 156 160 170 931 629 604 854 531 143
Total Liabilities & Shareholders' Equity		 1,382 1,359 1,288 1,299 1,297 1,243 1,234 1,255 1,157 1,155 1,165
Total Liabilities		 997 986 955 958 961 942 933 940 896 890 890
Claims and Claim Expense		 725 716 687 685 684 668 664 663 640 624 618
Unearned Premiums Liability		 130 128 124 126 126 124 128 132 133 139 144
Participating Policy Holder Equity		 38 37 35 35 34 34 34 34 33 34 34
Other Long-Term Liabilities		 103 105 109 113 116 115 106 111 90 93 95
Total Equity & Noncontrolling Interests		 385 373 333 341 336 301 301 314 261 266 275
Total Preferred & Common Equity		 385 373 333 341 336 301 301 314 261 266 275
Total Common Equity		 385 373 333 341 336 301 301 314 261 266 275
Common Stock		 220 220 221 222 222 223 224 224 225 226 226
Retained Earnings		 202 207 156 165 169 124 128 135 86 92 98
Treasury Stock		 -28 -35 -35 -35 -35 -37 -41 -42 -42 -45 -46
Accumulated Other Comprehensive Income / (Loss)		 -8.87 -20 -9.48 -12 -20 -8.74 -9.56 -2.68 -7.27 -7.56 -3.68

Annual Metrics And Ratios for AMERISAFE

This table displays calculated financial ratios and metrics derived from AMERISAFE's official financial filings.

Metric 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2014 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 13.38% -0.76% -1.07% -5.41% 0.68% -1.95% -8.34% -6.94% -6.71% 4.11% 0.71%
EBITDA Growth		 22.25% 31.51% 9.69% -25.34% 2.19% 25.92% -7.20% -23.06% -15.27% 8.11% -12.51%
EBIT Growth		 24.57% 36.91% 11.74% -27.11% 6.49% 31.90% -7.44% -25.69% -14.86% 14.39% -10.75%
NOPAT Growth		 22.98% 31.30% 10.51% -40.63% 54.94% 29.40% -6.57% -24.07% -15.44% 11.70% -10.74%
Net Income Growth		 22.98% 31.30% 10.51% -40.63% 54.94% 29.40% -6.57% -24.07% -15.44% 11.70% -10.74%
EPS Growth		 22.41% 29.93% 9.76% -40.74% 54.58% 29.38% -6.88% -24.16% -15.04% 12.15% -10.53%
Operating Cash Flow Growth		 8.92% -33.99% 23.00% 14.53% -24.88% -19.79% -19.57% -40.09% -25.76% 5.85% -18.94%
Free Cash Flow Firm Growth		 192.26% 169.86% 19.30% 1.67% 13.43% -17.25% 7.98% 34.93% 30.64% -36.66% 3.97%
Invested Capital Growth		 7.23% 1.57% 0.48% -6.74% -3.68% 4.99% 2.00% -9.00% -20.51% -7.87% -12.01%
Revenue Q/Q Growth		 -3.52% 0.29% 0.24% 5.10% -1.85% -16.67% 8.76% -0.87% 3,278.44% 0.12% -1.93%
EBITDA Q/Q Growth		 -36.38% 18.55% 1.66% 51.03% -8.71% 59.80% 53.12% 892.39% 127.29% -2.86% -9.53%
EBIT Q/Q Growth		 -41.24% 22.26% 2.11% 69.32% -9.01% 68.71% 60.81% 471.53% 123.68% -2.15% -9.41%
NOPAT Q/Q Growth		 -1.07% 9.66% -4.89% -28.50% 33.95% 19.63% -5.98% -27.51% 44.93% -2.51% -9.75%
Net Income Q/Q Growth		 -1.07% 9.66% -4.89% -28.50% 33.95% 19.63% -5.98% -27.51% 44.93% -2.51% -9.75%
EPS Q/Q Growth		 -1.05% 9.50% -5.37% -28.36% 33.94% 19.40% -6.09% -27.41% 45.45% -2.42% -9.69%
Operating Cash Flow Q/Q Growth		 6.43% -7.71% 1.07% -2.14% -0.97% -12.42% -5.68% -9.47% -36.81% 65.76% 39.58%
Free Cash Flow Firm Q/Q Growth		 263.23% 186.31% 20.73% -3.14% -2.38% 6.62% -1.18% 13.82% -5.50% -13.64% 9.18%
Invested Capital Q/Q Growth		 -0.34% -7.46% -10.51% -14.05% -10.73% -8.22% -8.94% -16.83% -14.90% -12.93% -18.14%
Profitability Metrics		 - - - - - - - - - - -
EBITDA Margin		 22.35% 29.61% 32.84% 25.92% 26.30% 33.78% 34.20% 28.28% 25.68% 26.67% 23.17%
EBIT Margin		 18.25% 25.18% 28.44% 21.92% 23.18% 31.19% 31.50% 25.15% 22.95% 25.22% 22.35%
Profit (Net Income) Margin		 13.28% 17.57% 19.63% 12.32% 18.96% 25.03% 25.51% 20.81% 18.87% 20.24% 17.94%
Tax Burden Percent		 72.77% 69.79% 69.02% 56.21% 81.79% 80.24% 81.00% 82.77% 82.20% 80.27% 80.28%
Interest Burden Percent		 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Effective Tax Rate		 27.23% 30.21% 30.98% 43.79% 18.21% 19.76% 19.00% 17.24% 17.80% 19.73% 19.72%
Return on Invested Capital (ROIC)		 12.43% 15.64% 17.11% 10.49% 17.15% 22.07% 19.93% 15.69% 15.51% 20.37% 20.17%
ROIC Less NNEP Spread (ROIC-NNEP)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Net Nonoperating Assets (RNNOA)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Equity (ROE)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Cash Return on Invested Capital (CROIC)		 5.44% 14.08% 16.63% 17.46% 20.90% 17.20% 17.95% 25.11% 38.37% 28.56% 32.94%
Operating Return on Assets (OROA)		 5.29% 6.82% 7.47% 5.42% 5.77% 7.68% 7.22% 5.53% 5.06% 6.19% 5.79%
Return on Assets (ROA)		 3.85% 4.76% 5.16% 3.04% 4.72% 6.16% 5.84% 4.58% 4.16% 4.97% 4.64%
Return on Common Equity (ROCE)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Equity Simple (ROE_SIMPLE)		 12.01% 15.52% 17.07% 10.87% 17.48% 21.55% 19.74% 16.47% 17.52% 21.24% 21.54%
Net Operating Profit after Tax (NOPAT)		 54 70 78 46 72 93 87 66 56 62 55
NOPAT Margin		 13.28% 17.57% 19.63% 12.32% 18.96% 25.03% 25.51% 20.81% 18.87% 20.24% 17.94%
Net Nonoperating Expense Percent (NNEP)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
SG&A Expenses to Revenue		 12.97% 12.96% 12.89% 13.44% 13.81% 14.08% 15.04% 14.95% 16.28% 16.56% 17.88%
Operating Expenses to Revenue		 81.75% 74.82% 71.56% 78.08% 76.82% 68.81% 68.50% 74.85% 77.05% 74.78% 77.65%
Earnings before Interest and Taxes (EBIT)		 74 101 113 82 88 116 107 79 68 77 69
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 90 119 130 97 99 125 116 89 76 82 72
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 0.88 1.13 1.48 1.68 1.73 2.05 1.89 2.12 2.62 2.83 3.82
Price to Tangible Book Value (P/TBV)		 0.88 1.13 1.48 1.68 1.73 2.05 1.89 2.12 2.62 2.83 3.82
Price to Revenue (P/Rev)		 0.97 1.29 1.71 1.91 1.87 2.38 2.45 2.68 2.83 2.69 3.18
Price to Earnings (P/E)		 7.34 7.31 8.69 15.48 9.88 9.52 9.59 12.90 14.98 13.31 17.71
Dividend Yield		 8.32% 12.79% 10.77% 11.03% 2.40% 9.84% 11.25% 11.78% 2.85% 3.16% 8.69%
Earnings Yield		 13.63% 13.68% 11.51% 6.46% 10.12% 10.50% 10.43% 7.75% 6.67% 7.51% 5.65%
Enterprise Value to Invested Capital (EV/IC)		 0.68 0.98 1.35 1.55 1.63 1.95 1.75 1.95 2.43 2.69 3.64
Enterprise Value to Revenue (EV/Rev)		 0.75 1.11 1.56 1.76 1.77 2.26 2.26 2.46 2.62 2.57 3.03
Enterprise Value to EBITDA (EV/EBITDA)		 3.35 3.75 4.74 6.79 6.72 6.70 6.62 8.70 10.20 9.63 13.10
Enterprise Value to EBIT (EV/EBIT)		 4.10 4.41 5.47 8.03 7.62 7.26 7.19 9.79 11.41 10.18 13.58
Enterprise Value to NOPAT (EV/NOPAT)		 5.64 6.33 7.93 14.28 9.32 9.05 8.87 11.82 13.88 12.69 16.92
Enterprise Value to Operating Cash Flow (EV/OCF)		 2.15 4.80 5.41 5.05 6.79 10.64 12.12 20.47 27.37 26.41 38.77
Enterprise Value to Free Cash Flow (EV/FCFF)		 12.87 7.03 8.16 8.58 7.65 11.61 9.85 7.39 5.61 9.05 10.36
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Financial Leverage		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Leverage Ratio		 3.23 3.28 3.32 3.45 3.63 3.58 3.41 3.43 3.73 4.10 4.34
Compound Leverage Factor		 3.23 3.28 3.32 3.45 3.63 3.58 3.41 3.43 3.73 4.10 4.34
Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 24 63 76 77 87 72 78 105 137 87 91
Operating Cash Flow to CapEx		 14,224.87% 9,743.86% 6,972.65% 27,366.11% 8,727.18% 7,743.03% 6,883.60% 2,983.43% 1,349.64% 5,396.38% 2,879.76%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.29 0.27 0.26 0.25 0.25 0.25 0.23 0.22 0.22 0.25 0.26
Fixed Asset Turnover		 54.64 59.75 61.90 58.79 61.00 58.84 54.26 49.99 43.08 45.21 50.51
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 447 454 456 425 410 430 439 399 317 292 257
Invested Capital Turnover		 0.94 0.89 0.87 0.85 0.90 0.88 0.78 0.75 0.82 1.01 1.12
Increase / (Decrease) in Invested Capital		 30 7.01 2.17 -31 -16 20 8.60 -39 -82 -25 -35
Enterprise Value (EV)		 303 446 618 660 668 839 768 778 772 788 938
Market Capitalization		 394 515 677 716 708 883 830 848 833 827 982
Book Value per Share		 $23.75 $23.78 $23.72 $22.11 $21.26 $22.29 $22.70 $20.62 $16.57 $15.25 $13.51
Tangible Book Value per Share		 $23.75 $23.78 $23.72 $22.11 $21.26 $22.29 $22.70 $20.62 $16.57 $15.25 $13.51
Total Capital		 447 454 456 425 410 430 439 399 317 292 257
Total Debt		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Long-Term Debt		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt		 -91 -69 -59 -56 -40 -44 -62 -71 -61 -39 -44
Capital Expenditures (CapEx)		 0.99 0.95 1.64 0.48 1.13 1.02 0.92 1.27 2.09 0.55 0.84
Net Nonoperating Expense (NNE)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Nonoperating Obligations (NNO)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Depreciation and Amortization (D&A)		 17 18 17 15 12 9.60 9.19 9.89 8.04 4.45 2.54
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $2.88 $3.72 $4.08 $2.41 $3.73 $4.82 $4.49 $3.40 $2.89 $3.24 $2.91
Adjusted Weighted Average Basic Shares Outstanding		 18.65M 18.94M 19.11M 19.17M 19.21M 19.25M 19.29M 19.33M 19.23M 19.15M 19.07M
Adjusted Diluted Earnings per Share		 $2.84 $3.69 $4.05 $2.40 $3.71 $4.80 $4.47 $3.39 $2.88 $3.23 $2.89
Adjusted Weighted Average Diluted Shares Outstanding		 18.93M 19.12M 19.20M 19.25M 19.29M 19.33M 19.36M 19.41M 19.32M 19.23M 19.16M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $4.82 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 18.92M 19.13M 19.23M 19.25M 19.27M 19.30M 19.33M 19.36M 19.16M 19.14M 19.05M
Normalized Net Operating Profit after Tax (NOPAT)		 54 70 78 46 72 93 87 66 56 62 55
Normalized NOPAT Margin		 13.28% 17.57% 19.63% 12.32% 18.96% 25.03% 25.51% 20.81% 18.87% 20.24% 17.94%
Pre Tax Income Margin		 18.25% 25.18% 28.44% 21.92% 23.18% 31.19% 31.50% 25.15% 22.95% 25.22% 22.35%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 69.07% 97.30% 97.75% 178.77% 117.95% 93.88% 102.51% 151.97% 180.62% 150.23% 154.12%
Augmented Payout Ratio		 69.07% 97.30% 97.75% 178.77% 117.95% 93.88% 102.51% 151.97% 202.90% 153.73% 163.36%

Quarterly Metrics And Ratios for AMERISAFE

This table displays calculated financial ratios and metrics derived from AMERISAFE's official financial filings.

Metric Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025
Period end date 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 3.81% 11.20% 1.77% 0.45% 2.61% 0.23% 8.34% -7.60% -9.81% 6.93% 4.17%
EBITDA Growth		 -3.40% 123.54% -13.59% -8.82% -6.02% -30.90% 38.54% -30.24% -45.83% 24.70% -3.22%
EBIT Growth		 0.53% 174.72% -8.36% -6.64% -3.67% -29.76% 44.34% -29.95% -45.91% 27.00% -1.75%
NOPAT Growth		 0.05% 154.84% -12.32% -7.69% -2.39% -29.65% 43.80% -31.21% -47.13% 26.94% -3.53%
Net Income Growth		 0.05% 154.84% -12.32% -7.69% -2.39% -29.65% 43.80% -31.21% -47.13% 26.94% -3.53%
EPS Growth		 1.12% 153.13% -11.86% -7.41% -2.22% -29.63% 44.23% -31.00% -46.59% 28.07% -4.00%
Operating Cash Flow Growth		 89.18% -59.28% -53.67% 150.39% -44.26% -135.62% 64.63% 172.93% -123.87% -225.73% 26.43%
Free Cash Flow Firm Growth		 14.46% -32.91% -60.26% -56.99% -38.96% -15.79% -23.91% 9.38% 1.12% -2.36% 49.06%
Invested Capital Growth		 -15.79% -11.54% -9.96% -7.87% -9.54% -11.62% -6.40% -12.01% -13.38% -11.77% -12.60%
Revenue Q/Q Growth		 -1.66% -3.54% -3.99% 10.29% 0.47% -5.79% 3.78% -5.93% -1.93% 11.70% 1.10%
EBITDA Q/Q Growth		 -16.02% -9.91% -36.19% 88.88% -13.45% -33.76% 27.95% -4.90% -32.79% 52.49% -0.71%
EBIT Q/Q Growth		 -16.04% -9.13% -37.00% 94.26% -13.37% -33.75% 29.46% -5.73% -33.10% 55.56% 0.15%
NOPAT Q/Q Growth		 -16.55% -9.87% -36.26% 92.56% -11.76% -35.05% 30.30% -7.89% -32.17% 55.94% -0.98%
Net Income Q/Q Growth		 -16.55% -9.87% -36.26% 92.56% -11.76% -35.05% 30.30% -7.89% -32.17% 55.94% -0.98%
EPS Q/Q Growth		 -16.67% -10.00% -35.80% 92.31% -12.00% -35.23% 31.58% -8.00% -31.88% 55.32% -1.37%
Operating Cash Flow Q/Q Growth		 271.06% -45.96% -29.48% -22.70% 89.21% -134.53% 425.96% 28.15% -116.55% -371.15% 226.52%
Free Cash Flow Firm Q/Q Growth		 -22.32% -24.71% -21.57% -6.23% 10.24% 3.87% -29.13% 34.79% 1.92% 0.30% 8.18%
Invested Capital Q/Q Growth		 4.86% 2.32% -1.38% -12.93% 2.96% -0.03% 4.45% -18.14% 1.35% 1.82% 3.47%
Profitability Metrics		 - - - - - - - - - - -
EBITDA Margin		 29.29% 27.36% 18.18% 31.14% 26.83% 18.86% 23.25% 23.51% 16.11% 21.99% 21.60%
EBIT Margin		 27.45% 25.86% 16.97% 29.89% 25.77% 18.12% 22.61% 22.66% 15.46% 21.53% 21.32%
Profit (Net Income) Margin		 22.11% 20.65% 13.71% 23.94% 21.03% 14.50% 18.20% 17.82% 12.33% 17.21% 16.86%
Tax Burden Percent		 80.52% 79.86% 80.81% 80.10% 81.59% 79.98% 80.50% 78.66% 79.75% 79.95% 79.05%
Interest Burden Percent		 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Effective Tax Rate		 19.48% 20.14% 19.19% 19.90% 18.41% 20.02% 19.50% 21.34% 20.25% 20.05% 20.95%
Return on Invested Capital (ROIC)		 18.07% 17.38% 11.86% 24.09% 20.49% 13.97% 17.64% 20.04% 13.21% 18.61% 17.72%
ROIC Less NNEP Spread (ROIC-NNEP)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Net Nonoperating Assets (RNNOA)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Equity (ROE)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Cash Return on Invested Capital (CROIC)		 32.42% 30.19% 28.45% 28.56% 29.48% 30.13% 25.51% 32.94% 31.23% 30.30% 30.39%
Operating Return on Assets (OROA)		 6.10% 5.89% 3.92% 7.34% 6.29% 4.42% 5.59% 5.87% 3.88% 5.52% 5.46%
Return on Assets (ROA)		 4.91% 4.70% 3.16% 5.88% 5.13% 3.54% 4.50% 4.62% 3.09% 4.42% 4.31%
Return on Common Equity (ROCE)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Equity Simple (ROE_SIMPLE)		 16.71% 19.12% 18.97% 0.00% 20.49% 18.96% 19.54% 0.00% 18.20% 18.99% 18.17%
Net Operating Profit after Tax (NOPAT)		 17 16 9.96 19 17 11 14 13 8.95 14 14
NOPAT Margin		 22.11% 20.65% 13.71% 23.94% 21.03% 14.50% 18.20% 17.82% 12.33% 17.21% 16.86%
Net Nonoperating Expense Percent (NNEP)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
SG&A Expenses to Revenue		 15.08% 16.58% 17.73% 16.92% 16.63% 17.35% 17.01% 20.70% 19.75% 16.89% 17.72%
Operating Expenses to Revenue		 72.55% 74.14% 83.03% 70.11% 74.23% 81.88% 77.39% 77.34% 84.54% 78.47% 78.68%
Earnings before Interest and Taxes (EBIT)		 22 20 12 24 21 14 18 17 11 17 17
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 23 21 13 25 22 14 18 17 12 18 18
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 2.54 2.72 2.59 2.83 3.17 2.79 2.93 3.82 3.84 3.14 3.03
Price to Tangible Book Value (P/TBV)		 2.54 2.72 2.59 2.83 3.17 2.79 2.93 3.82 3.84 3.14 3.03
Price to Revenue (P/Rev)		 2.84 3.03 2.84 2.69 3.09 2.72 2.92 3.18 3.32 2.72 2.69
Price to Earnings (P/E)		 15.18 14.21 13.64 13.31 15.46 14.72 15.00 17.71 21.09 16.52 16.68
Dividend Yield		 2.88% 2.69% 2.94% 3.16% 2.79% 3.24% 3.00% 8.69% 8.56% 10.34% 10.36%
Earnings Yield		 6.59% 7.04% 7.33% 7.51% 6.47% 6.79% 6.67% 5.65% 4.74% 6.05% 6.00%
Enterprise Value to Invested Capital (EV/IC)		 2.41 2.62 2.41 2.69 3.06 2.69 2.73 3.64 3.67 2.95 2.83
Enterprise Value to Revenue (EV/Rev)		 2.70 2.92 2.64 2.57 2.98 2.62 2.72 3.03 3.18 2.56 2.51
Enterprise Value to EBITDA (EV/EBITDA)		 10.72 10.32 9.61 9.63 11.44 10.93 10.84 13.10 15.50 12.03 12.03
Enterprise Value to EBIT (EV/EBIT)		 11.85 11.11 10.24 10.18 12.02 11.44 11.25 13.58 16.06 12.41 12.36
Enterprise Value to NOPAT (EV/NOPAT)		 14.44 13.69 12.71 12.69 14.92 14.18 13.97 16.92 20.15 15.56 15.58
Enterprise Value to Operating Cash Flow (EV/OCF)		 23.24 37.21 44.98 26.41 38.55 57.75 49.50 38.77 64.22 86.78 68.99
Enterprise Value to Free Cash Flow (EV/FCFF)		 6.80 8.14 8.03 9.05 9.85 8.37 10.34 10.36 10.90 9.14 8.69
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Financial Leverage		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Leverage Ratio		 3.68 3.69 3.75 4.10 3.99 3.95 3.92 4.34 4.27 4.22 4.11
Compound Leverage Factor		 3.68 3.69 3.75 4.10 3.99 3.95 3.92 4.34 4.27 4.22 4.11
Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 80 60 47 44 49 51 36 48 49 49 53
Operating Cash Flow to CapEx		 42,081.25% 145,540.00% 1,047.35% 15,257.69% 1,006.17% -4,628.57% 35,204.17% 77,335.71% -89,600.00% -780.31% 1,198.88%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.22 0.23 0.23 0.25 0.24 0.24 0.25 0.26 0.25 0.26 0.26
Fixed Asset Turnover		 44.65 45.39 43.60 45.21 45.18 47.75 49.20 50.51 48.41 47.33 46.22
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 333 341 336 292 301 301 314 257 261 266 275
Invested Capital Turnover		 0.82 0.84 0.86 1.01 0.97 0.96 0.97 1.12 1.07 1.08 1.05
Increase / (Decrease) in Invested Capital		 -62 -44 -37 -25 -32 -40 -22 -35 -40 -35 -40
Enterprise Value (EV)		 803 891 810 788 921 809 858 938 956 785 778
Market Capitalization		 844 925 869 827 954 840 922 982 1,001 833 833
Book Value per Share		 $17.38 $17.78 $17.51 $15.25 $15.75 $15.73 $16.49 $13.51 $13.69 $13.94 $14.47
Tangible Book Value per Share		 $17.38 $17.78 $17.51 $15.25 $15.75 $15.73 $16.49 $13.51 $13.69 $13.94 $14.47
Total Capital		 333 341 336 292 301 301 314 257 261 266 275
Total Debt		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Long-Term Debt		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt		 -41 -34 -59 -39 -33 -31 -64 -44 -45 -48 -55
Capital Expenditures (CapEx)		 0.03 0.01 0.49 0.03 0.75 0.06 0.02 0.01 0.00 1.08 0.89
Net Nonoperating Expense (NNE)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Nonoperating Obligations (NNO)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Depreciation and Amortization (D&A)		 1.44 1.13 0.88 1.00 0.85 0.56 0.51 0.63 0.48 0.38 0.23
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $0.91 $0.82 $0.52 $0.99 $0.89 $0.58 $0.75 $0.69 $0.47 $0.73 $0.73
Adjusted Weighted Average Basic Shares Outstanding		 19.13M 19.14M 19.16M 19.15M 19.12M 19.08M 19.04M 19.07M 19.04M 19.04M 18.98M
Adjusted Diluted Earnings per Share		 $0.90 $0.81 $0.52 $1.00 $0.88 $0.57 $0.75 $0.69 $0.47 $0.73 $0.72
Adjusted Weighted Average Diluted Shares Outstanding		 19.24M 19.20M 19.22M 19.23M 19.21M 19.15M 19.11M 19.16M 19.15M 19.12M 19.07M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 19.15M 19.18M 19.18M 19.14M 19.14M 19.07M 19.05M 19.05M 19.05M 18.99M 18.92M
Normalized Net Operating Profit after Tax (NOPAT)		 17 16 9.96 19 17 11 14 13 8.95 14 14
Normalized NOPAT Margin		 22.11% 20.65% 13.71% 23.94% 21.03% 14.50% 18.20% 17.82% 12.33% 17.21% 16.86%
Pre Tax Income Margin		 27.45% 25.86% 16.97% 29.89% 25.77% 18.12% 22.61% 22.66% 15.46% 21.53% 21.32%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 181.53% 155.95% 160.37% 150.23% 152.17% 165.38% 154.48% 154.12% 180.75% 170.90% 173.45%
Augmented Payout Ratio		 181.53% 166.22% 160.60% 153.73% 152.17% 176.39% 166.35% 163.36% 180.75% 178.44% 181.76%

Financials Breakdown Chart

Key Financial Trends

AMERISAFE’s latest quarter showed solid profitability, but the balance sheet and cash flow picture reflects a company that is still heavily influenced by its investment portfolio and dividend policy. For Q3 2025, net income came in at $13.8 million, slightly below Q2 2025’s $14.0 million and Q3 2024’s $14.3 million. Revenue was also relatively stable, with premiums earned rising year over year, while investment gains remained an important contributor to results.

On the positive side, underwriting and revenue trends have been steady over the last several quarters. Premiums earned rose to $71.2 million in Q3 2025 from $69.4 million in Q2 2025 and $67.1 million in Q3 2024. That suggests the core business is still expanding modestly. AMERISAFE also continues to generate meaningful quarterly profits, with diluted EPS of $0.72 in Q3 2025.

Cash generation remains a strength, but it has been uneven. Q3 2025 operating cash flow was $10.7 million, a sharp rebound from Q2 2025, when operating cash flow was negative ($8.4 million). In Q1 2025, operating cash flow was also negative ($1.8 million). That makes Q3 a clear improvement, though the prior two quarters show that cash from operations can swing significantly.

The company’s investment portfolio still drives a big part of the story. AMERISAFE held $762.3 million in trading account securities at the end of Q3 2025, up from $374.1 million in Q2 2025. That is a major quarter-over-quarter increase and helps explain the large jump in other assets and total assets. Total assets increased to $1.16 billion from $1.16 billion in Q2, but the composition shifted materially toward securities.

Equity has improved, though liabilities remain large. Total common equity rose to $274.8 million in Q3 2025 from $265.6 million in Q2 2025. Retained earnings also increased. Still, total liabilities were $890.2 million, which is substantial relative to equity, reflecting the insurance business model and reserve-heavy balance sheet.

Over the longer arc, profitability has held up reasonably well, but there are signs of some moderation. In 2024, quarterly net income generally ranged from about $11 million to $19 million, with Q4 2024 at $13.2 million and Q1 2025 at $8.9 million. The latest quarter recovered from that weaker Q1, but earnings are not showing a strong uptrend.

Dividends remain a consistent use of cash. AMERISAFE paid $7.5 million in dividends in Q3 2025, after $7.5 million in Q2 2025 and $7.4 million in Q1 2025. The quarterly dividend per share has been steady at $0.39 in 2025. That supports the stock’s income appeal, but it also means a large portion of cash flow gets returned to shareholders.

  • Premiums earned increased to $71.2 million in Q3 2025 from $69.4 million in Q2 2025 and $67.1 million in Q3 2024.
  • Q3 2025 operating cash flow rebounded to $10.7 million after negative operating cash flow in Q2 and Q1 2025.
  • Net income remained profitable at $13.8 million in Q3 2025, with diluted EPS of $0.72.
  • Total common equity improved to $274.8 million from $265.6 million in Q2 2025.
  • The company continued to support shareholders with a $0.39 quarterly dividend per share in 2025.
  • Investment gains remain a meaningful earnings driver, with Q3 2025 capital gains of $10.7 million contributing materially to results.
  • Balance sheet composition changed sharply in Q3 2025, with trading account securities jumping to $762.3 million.
  • Liabilities remain high relative to equity, which is typical for an insurer but still worth monitoring.
  • Operating cash flow was negative in Q2 and Q1 2025, showing that cash generation can be volatile quarter to quarter.
  • Quarterly earnings have softened versus 2024 peaks, suggesting profitability has not been accelerating.

Bottom line: AMERISAFE looks like a consistently profitable insurer with a healthy dividend and a solid capital base, but investors should watch the volatility in operating cash flow and the heavy dependence on investment results. The core business appears stable, yet not especially fast-growing.

06/15/26 08:32 AM ETAI Generated. May Contain Errors.

AMERISAFE Financials - Frequently Asked Questions

According to the most recent income statement we have on file, AMERISAFE's fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

The last 5 years of AMERISAFE's net income performance:
  • 2020: $86.60 million
  • 2021: $65.76 million
  • 2022: $55.60 million
  • 2023: $62.11 million
  • 2024: $55.44 million
Find out what analysts predict for AMERISAFE in the coming months.

Over the last 10 years, AMERISAFE's total revenue changed from $404.02 million in 2014 to $309.04 million in 2024, a change of -23.5%.

AMERISAFE's total liabilities were at $900.45 million at the end of 2024, a 3.9% decrease from 2023, and a 10.9% decrease since 2014.

In the past 10 years, AMERISAFE's cash and equivalents has ranged from $38.68 million in 2023 to $90.96 million in 2014, and is currently $44.05 million as of their latest financial filing in 2024.

Over the last 10 years, AMERISAFE's book value per share changed from 23.75 in 2014 to 13.51 in 2024, a change of -43.1%.


Related Companies

Financial statements for NASDAQ:AMSF last updated on 11/14/2025 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners
The 1934 playbook
In 1934, a legal government maneuver transferred billions in wealth overnight. Most Americans never saw it com...
American Alternative | Sponsoredtc pixel
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
Is SpaceX really worth 1.78 Trillion?
With SpaceX approaching a near-$2 trillion valuation, most investors are focused on the IPO itself - but analy...
InvestPub | Sponsoredtc pixel
Hey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...
After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...
Banyan Hill Publishing | Sponsoredtc pixel
CODE RED: AI Meltdown Imminent?
After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...
Paradigm Press | Sponsoredtc pixel
SpaceX is chump change compared to Elon’s $20T ‘iPhone’
Early Apple investors saw peak gains as high as 7,537% after the iPhone launched. Now, multiple insider source...
StocksToTrade | Sponsoredtc pixel